BioSpace News Archive

Drug Development

12 Clinical Successes of 2017

Now that we’ve got the bad news out of the way, we’re here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months.

December 18, 2017
·
1 min read
Deals

Gilead Could Acquire Galapagos Within Weeks

Investors are salivating at the possibility of a hot merger-and-acquisition market in 2018.

December 18, 2017
·
3 min read
·
Mark Terry
BioMidwest

3 Med-Tech Stocks as Huge Buys in 2018

Stifel’s medical technology team recently visited with three top companies in their coverage universe.

December 18, 2017
·
1 min read
Biotech Bay

Bay Area Bigfoot Biomedical Bags $37M Series B Financing

The round was co-led by funds managed by new investor Janus Henderson Investors.

December 18, 2017
·
2 min read
·
Mark Terry
Deals

Novartis Buys Rare Drug Voucher for $130M From Ultragenyx

Ultragenyx CEO Emil Kakkis said the sale of the PRV will provide the company with an “important source of non-dilutive capital” that will be used to advance the company’s pipeline of rare and ultra-rare therapies.

December 18, 2017
·
2 min read
·
Alex Keown
FDA

Aerie’s Glaucoma Drug Scores Early FDA Approval

Christmas came a week early for Aerie Pharmaceuticals.

December 18, 2017
·
2 min read
·
Alex Keown